| Atglistatin |
ATGLISTATIN |
1469924-27-3 |
| KRCA-0008 |
1,1'-((((5-氯嘧啶-2,4-二基)双(氮烷二基))双(3-甲氧基-4,1-亚苯基))双(哌嗪-4,1-二基))双(乙-1-酮) |
1472795-20-2 |
| 7ACC-2 |
7ACC-2 |
1472624-85-3 |
| N-(4-ethylphenyl)-3-(hydroxymethyl)-N-isobutyl-4-((tetrahydro-2H-pyran-4-yl)methoxy)benzenesulfonamide |
GSK2981278 |
1474110-21-8 |
| Nrf1-activator-1 |
NRF1-ACTIVATOR-1 |
1474034-05-3 |
| NITD-349 |
1473450-62-2 |
1473450-62-2 |
| CAY10683 (SantacruzaMate A) |
HDAC抑制剂 |
1477949-42-0 |
| UNC-0642 |
2-(4,4-二氟-1-哌啶基)-6-甲氧基-N-[1-异丙基-4-哌啶基]-7-[3-(1-吡咯烷基)丙氧基]-4-喹唑啉胺 |
1481677-78-4 |
| fulacimstat(BAY1142524) |
CS-2859 |
1488354-15-9 |
| HUHS015 |
HUHS015 |
1453097-13-6 |
| ASP5878 |
ASP-5878 |
1453208-66-6 |
| GDC-0994 |
GDC-0994 |
1453848-26-4 |
| LDC4297 |
CS-2539 |
1453834-21-3 |
| Rovazolac |
乙基2-[5-[3'-(甲基磺酰基)联苯基-4-基]-3-(三氟甲基)-1H-吡唑-1-基]乙酸酯 |
1454288-88-0 |
| PU-WS13 |
6-氨基-8-[(3,5-二氯苯基)硫基]-N-异丙基-9H-嘌呤-9-丙胺 |
1454619-14-7 |
| N-((4,5-difluoro-1H-benzo[d]imidazol-2-yl)methyl)-9-(3-fluorophenyl)-2-morpholino-9H-purin-6-amine |
SR-3029 |
1454585-06-8 |
| LY-3009120 |
LY-3009120 |
1454682-72-4 |
| IN00076730 |
REL-(1ALPHA,3R,4BETA,5S)-5'-溴-4-甲氧基-3,5-二甲基螺[环己烷-1,2'-[2H]茚]-3'(1'H)-酮 |
1454700-89-0 |
| SH-4-54 |
SH-4-54 |
1456632-40-8 |
| SH5-07 |
1456632-41-9 |
1456632-41-9 |
